Literature DB >> 8621361

Carboxamides and hydrazide of glycopeptide antibiotic eremomycin. Synthesis and antibacterial activity.

A Y Pavlov1, T F Berdnikova, E N Olsufyeva, O V Miroshnikova, S T Filipposyanz, M N Preobrazhenskaya, C Sottani, L Columbo, B P Goldstein.   

Abstract

Carboxamides and hydrazide of glycopeptide antibiotic eremomycin were obtained by a direct reaction of the carboxy group of eremomycin with an appropriate amine or hydrazine using diphenyl phosphorazidate as a condencing agent. Eremomycin hydrazide was also obtained by hydrazinolysis of the eremomycin methyl ester. Use of dicyclohexylcarbodiimide or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide for amidation led to the corresponding eremomycin ureides. The ESI-MS data indicate that eremomycin and its amides exist as dimers. The carboxamide, methylamide and benzylamide of eremomycin were as active against Gram-positive bacteria as the parent antibiotic, and the methylamide, benzylamide and hydrazide were almost an order of magnitude more active than eremomycin against Staphylococcus epidermidis clinical isolates in vitro. Amide of eremomycin as well as ureides were devoid of histamine liberating properties, which demonstrates that protection of the carboxyl group leads to a decrease in the allergenic properties.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621361     DOI: 10.7164/antibiotics.49.194

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  Identification of Chemical Compounds That Inhibit the Function of Glutamyl-tRNA Synthetase from Pseudomonas aeruginosa.

Authors:  Yanmei Hu; Edgar Guerrero; Megan Keniry; Joel Manrrique; James M Bullard
Journal:  J Biomol Screen       Date:  2015-06-26

2.  Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.

Authors:  Evgenia N Olsufyeva; Andrey E Shchekotikhin; Elena N Bychkova; Eleonora R Pereverzeva; Ivan D Treshalin; Elena P Mirchink; Elena B Isakova; Mikhail G Chernobrovkin; Roman S Kozlov; Andrey V Dekhnich; Maria N Preobrazhenskaya
Journal:  Drug Des Devel Ther       Date:  2018-09-10       Impact factor: 4.162

3.  Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.

Authors:  Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; Erik De Clercq; Marc Van Ranst; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Svetlana E Solovieva; Maria N Preobrazhenskaya
Journal:  Antiviral Res       Date:  2006-04-06       Impact factor: 5.970

Review 4.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.